Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT

Digestive Diseases and Sciences

Volumn 47, Issue 3, 2002, Pages 556-561

  Marinho, Rui ^a   Pinto, Ruth ^a   Santos, Maria Livia ^a   De Moura, Miguel Carneiro ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Aminotransferases; Hepatitis C; Hepatocellular carcinoma; Indomethacin; T lymphocytes

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN INHIBITOR; VIRUS ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFECTION; LIVER CELL CARCINOMA; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SUPPRESSOR CELL;

ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; DINOPROSTONE; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; INDOMETHACIN; LIVER; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY;

EID: 0036122643     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017911918332     Document Type: Article

References (42)

1. Consensus statement, EASL International Consensus Conference on Hepatitis C
2. Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis
3. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments
4. Limited humoral immunity in hepatitis C virus infection
5. Persistence of HCV despite antibodies to both putative envelope glicoproteins
6. Hepatitis C virus-specific T lymphocytes responses
7. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
8. Analysis of a successful immune response against hepatitis C virus
9. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
10. The mechanisms of chronicity in hepatitis C virus infection
11. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
12. T-lymphocyte response to hepatitis C virus in different clinical courses of infection
13. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
14. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C
15. Lymphoproliferative responses to hepatitis C virus core, E1, E 2, and NS3 in patients with chronic hepatitis C infection treated with interferon alpha
16. Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view
17. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
18. 2
19. Suppressor adherent cells in human tuberculosis
20. Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens
21. Evidence for prostaglandinproducing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization
22. Prostaglandin-producing suppressor cells in Hodgkin's disease
23. Indomethacin sensitive suppressor cells in Crohn's disease: A possible role in decreased lymphocyte responsiveness
24. Suppressor cell function in sarcoidosis
25. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids
26. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation
27. Immunoregulatory adherent cells in human tuberculosis: Radiation-sensitive antigen-specific suppression by monocytes
28. Antigen responsiveness during tuberculosis: Regulatory interactions of T cell subpopulations and adherent cells
29. Prostaglandins as endogenous mediators of interleukin 1 production
30. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
31. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human killer cell activity
32. Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility
33. Role of the specific T-cell response for clearance and control of hepatitis C virus
34. Is there a role for immune responses in the pathogenesis in hepatitis C?
35. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C virus infection and healthy anti-hepatitis C virus-positive blood donors without viremia
36. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens
37. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
38. Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections
39. + T lymphocytes epitope of hepatitis C virus antigens and their relevance during the course of chronic infection
40. 2) therapy for chronic viral hepatitis B and C
41. Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT 1 phosphorylation